Extra Strength Joint Care
Natural health product licensed in Canada
- Other names
- Lakota
- Licence holder
- HPI Health Products Inc.
- NPN or DIN-HM
- 80035960
- Status
- Active licence
- Licence date
- 28 September 2012
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Harpagophytum procumbens Source : Harpagophytum procumbens, racine | 15 mg | Not calculated |
| Yucca schidigera Source : Racine | 15 mg | Not calculated |
| Yucca schidigera Source : Yucca schidigera | 15 mg | Not calculated |
| Boswellia serrata Source : Boswellia serrata Potency : 65 % Boswellic acid | 60 mg | Not calculated |
| Boswellia serrata Source : Résine d'écorce Potency : 65 % Boswellic acid | 60 mg | Not calculated |
| Manganèse Source : Produit de chélation de manganèse et d'acide aminé | 750 mcg | Not calculated |
| Manganèse Source : Synthétique | 750 mcg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes | 375 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : exosquelettes de crevettes | 375 mg | Not calculated |
| Tanacetum parthenium Source : Tanacetum parthenium, feuille | 10 mg | Not calculated |
Non-medicinal ingredients
Calcium phosphate, Cellulose, microcristalline, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Caplet | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining good cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80035960
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.